This was already stated in the announcement of the appointment of Torreya on February 1.
Torreya will work closely with Neuren management and assist the board in considering all potential corporate transactions including individual products, territories, or Neuren’s entire business.
- Forums
- ASX - By Stock
- NEU
- Ann: Annual Report to shareholders
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.00%
!
$16.48

Ann: Annual Report to shareholders, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$16.48 |
Change
0.000(0.00%) |
Mkt cap ! $2.076B |
Open | High | Low | Value | Volume |
$16.48 | $16.77 | $16.28 | $3.108M | 188.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 105 | $16.48 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.54 | 885 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1 | 17.470 |
3 | 35 | 16.850 |
1 | 50 | 16.700 |
2 | 133 | 16.610 |
2 | 183 | 16.490 |
Price($) | Vol. | No. |
---|---|---|
16.420 | 1 | 1 |
16.610 | 1 | 1 |
16.620 | 97 | 1 |
16.800 | 118 | 2 |
16.890 | 1266 | 1 |
Last trade - 16.13pm 28/07/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |